Insulin resistance in heart failure: widening the divide between reduced and preserved ejection fraction?

被引：3

作者：

Greene, Stephen J. ^{[1
]}

Fonarow, Gregg C. ^{[2
]}

机构：

[1] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA

[2] Univ Calif Los Angeles, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA

来源：

EUROPEAN JOURNAL OF HEART FAILURE | 2015年 / 17卷 / 10期

关键词：

DIABETES-MELLITUS; COMORBIDITIES; DYSFUNCTION; MORTALITY; OUTCOMES; DISEASE; IMPACT;

D O I：

10.1002/ejhf.337

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：991 / 993

页数：3

共 17 条

[1] Relationship of Hemoglobin A1C and Mortality in Heart Failure Patients With Diabetes [J].

Aguilar, David ;

Bozkurt, Biykem ;

Ramasubbu, Kumudha ;

Deswal, Anita .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (05) :422-428

[2] The war against heart failure: the Lancet lecture [J].

Braunwald, Eugene .

LANCET, 2015, 385 (9970) :812-824

[3] Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: A retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention Trial [J].

Das, SR ;

Drazner, MH ;

Yancy, CW ;

Stevenson, LW ;

Gersh, BJ ;

Dries, DL .

AMERICAN HEART JOURNAL, 2004, 148 (05) :883-888

[4] Impact of Diabetes on Epidemiology, Treatment, and Outcomes of Patients With Heart Failure [J].

Dei Cas, Alessandra ;

Khan, Sadiya S. ;

Butler, Javed ;

Mentz, Robert J. ;

Bonow, Robert O. ;

Avogaro, Angelo ;

Tschoepe, Diethelm ;

Doehner, Wolfram ;

Greene, Stephen J. ;

Senni, Michele ;

Gheorghiade, Mihai ;

Fonarow, Gregg C. .

JACC-HEART FAILURE, 2015, 3 (02) :136-145

[5] Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure [J].

Doehner, W ;

Rauchhaus, M ;

Ponikowski, P ;

Godsland, IF ;

von Haehling, S ;

Okonko, DO ;

Leyva, F ;

Proudler, AJ ;

Coats, AJS ;

Anker, SD .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (06) :1019-1026

[6] Critical appraisal of the obesity paradox in cardiovascular disease: How to manage patients with overweight in heart failure? [J].

Doehner, Wolfram .

HEART FAILURE REVIEWS, 2014, 19 (05) :637-644

[7]

Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743

[8] Prognostic Significance of Serum Total Cholesterol and Triglyceride Levels in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial) [J].

Greene, Stephen J. ;

Vaduganathan, Muthiah ;

Lupi, Laura ;

Ambrosy, Andrew P. ;

Mentz, Robert J. ;

Konstam, Marvin A. ;

Nodari, Savina ;

Subacius, Hans P. ;

Fonarow, Gregg C. ;

Bonow, Robert O. ;

Gheorghiade, Mihai .

AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (04) :574-581

[9] Body Mass Index and Adverse Cardiovascular Outcomes in Heart Failure Patients With Preserved Ejection Fraction Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial [J].

Haass, Markus ;

Kitzman, Dalane W. ;

Anand, Inder S. ;

Miller, Alan ;

Zile, Michael R. ;

Massie, Barry M. ;

Carson, Peter E. .

CIRCULATION-HEART FAILURE, 2011, 4 (03) :324-331

[10] Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial [J].

Home, Philip D. ;

Pocock, Stuart J. ;

Beck-Nielsen, Henning ;

Curtis, Paula S. ;

Gomis, Ramon ;

Hanefeld, Markolf ;

Jones, Nigel P. ;

Komajda, Michel ;

McMurray, John J. V. .

LANCET, 2009, 373 (9681) :2125-2135

← 1 2 →